ProtoKinetix Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
1.50
3.00
3.00
3
Gross Income
-
-
1.50
3.00
3.00
3
SG&A Expense
422.20
384.20
1,256.60
1,521.60
1,509.00
1,213
EBIT
422.20
384.20
1,258.10
1,524.60
1,512.00
1,216
Unusual Expense
-
250.10
7.30
-
-
-
Interest Expense
26.40
34.40
4.00
0.00
1.70
0.30
Pretax Income
448.60
168.50
1,254.80
1,524.60
1,513.60
1,216.30
Consolidated Net Income
448.60
168.50
1,254.80
1,524.60
1,513.60
1,216.30
Net Income
448.60
168.50
1,254.80
1,524.60
1,513.60
1,216.30
Net Income After Extraordinaries
448.60
168.50
1,254.80
1,524.60
1,513.60
1,216.30
Net Income Available to Common
448.60
168.50
1,254.80
1,524.60
1,513.60
1,216.30
EPS (Basic)
0.00
0.00
0.01
0.01
0.01
-
Basic Shares Outstanding
137,107.20
172,401.50
197,978.10
211,613.40
246,598.50
256,217.20
EPS (Diluted)
0.00
0.00
0.01
0.01
0.01
-
Diluted Shares Outstanding
137,107.20
172,401.50
197,978.10
211,613.40
246,598.50
256,217.20
EBITDA
422.20
384.20
1,256.60
1,521.60
1,509.00
1,213

About ProtoKinetix

View Profile
Address
412 Mulberry Street
Marietta Ohio 45750
United States
Employees -
Website http://www.protokinetix.com
Updated 07/08/2019
Protokinetix, Inc. is a research and development stage biotechnology company, which engages in the scientific medical research of anti-aging glycoproteins. The company was founded on December 23, 1999 and is headquartered in St. Marys, WV.